• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人β3-肾上腺素能受体cDNA的分子克隆

Molecular cloning of a human beta 3-adrenergic receptor cDNA.

作者信息

Lelias J M, Kaghad M, Rodriguez M, Chalon P, Bonnin J, Dupre I, Delpech B, Bensaid M, LeFur G, Ferrara P

机构信息

Laboratoire de Biologie Moleculaire, Sanofi Elf Biorecherches, Labege, France.

出版信息

FEBS Lett. 1993 Jun 14;324(2):127-30. doi: 10.1016/0014-5793(93)81377-c.

DOI:10.1016/0014-5793(93)81377-c
PMID:8389717
Abstract

We report the molecular cloning of a beta 3-adrenergic receptor [beta 3-AR] cDNA from human brown adipose tissue. The cDNA-encoded protein is identical to the previously cloned beta 3-AR but with 6 additional amino acids at the C-terminus. The C-terminus is shared by the beta 3 receptors expressed in human neuroblastoma cells [SK-N-MC] [Mol. Pharmacol. 42 (1992) 964-970]. Furthermore, using a polymerase chain reaction strategy we have cloned and sequenced the beta 3-AR introns. Sequence analysis demonstrates that the human beta 3-AR gene comprises at least 3 exons and 2 introns and that the most abundant beta 3-AR transcripts encode a protein with an exon 3-derived C-terminus. Interestingly, although a similar organization has been found in rodent genes, the rat beta 3-AR transcripts encode a receptor with an exon 2-derived C-terminus.

摘要

我们报道了从人棕色脂肪组织中克隆β3-肾上腺素能受体[β3-AR] cDNA的过程。该cDNA编码的蛋白与先前克隆的β3-AR相同,但在C末端有6个额外的氨基酸。人神经母细胞瘤细胞[SK-N-MC]中表达的β3受体也具有相同的C末端[《分子药理学》42(1992)964 - 970]。此外,我们采用聚合酶链反应策略克隆并测序了β3-AR内含子。序列分析表明,人β3-AR基因至少包含3个外显子和2个内含子,且最丰富的β3-AR转录本编码一种具有源自外显子3的C末端的蛋白。有趣的是,尽管在啮齿动物基因中发现了类似的结构,但大鼠β3-AR转录本编码的受体具有源自外显子2的C末端。

相似文献

1
Molecular cloning of a human beta 3-adrenergic receptor cDNA.人β3-肾上腺素能受体cDNA的分子克隆
FEBS Lett. 1993 Jun 14;324(2):127-30. doi: 10.1016/0014-5793(93)81377-c.
2
The rat beta 3-adrenergic receptor gene contains an intron.
FEBS Lett. 1993 Mar 8;318(3):223-6. doi: 10.1016/0014-5793(93)80516-w.
3
Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.牛α1C - 肾上腺素能受体大鼠同源物的克隆、表达及组织分布为其归为α1A亚型提供了证据。
Mol Pharmacol. 1994 Nov;46(5):823-31.
4
Characterization of the human beta 3-adrenergic receptor gene.人类β3-肾上腺素能受体基因的特征分析
Mol Pharmacol. 1993 Aug;44(2):264-70.
5
Cloning, mapping and genomic organization of a fish C-type lectin gene from homozygous clones of rainbow trout (Oncorhynchus mykiss).虹鳟(Oncorhynchus mykiss)纯合克隆中一种鱼类C型凝集素基因的克隆、定位及基因组结构
Biochim Biophys Acta. 2000 Nov 15;1494(1-2):14-22. doi: 10.1016/s0167-4781(00)00198-6.
6
Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block.
Mol Pharmacol. 1992 Dec;42(6):964-70.
7
Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells.人α1d - 肾上腺素能受体的克隆及三种人类亚型在SK - N - MC细胞中的诱导表达。
Mol Pharmacol. 1995 May;47(5):977-85.
8
The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes.人类和小鼠β3-肾上腺素能受体基因的启动子及内含子/外显子结构。
Eur J Biochem. 1993 May 1;213(3):1117-24. doi: 10.1111/j.1432-1033.1993.tb17861.x.
9
Molecular cloning and pharmacological characterization of the bovine beta 3-adrenergic receptor.牛β3 - 肾上腺素能受体的分子克隆与药理学特性研究
Eur J Biochem. 1995 May 15;230(1):350-8.
10
Mice expressing human but not murine beta3-adrenergic receptors under the control of human gene regulatory elements.在人类基因调控元件控制下表达人类而非小鼠β3-肾上腺素能受体的小鼠。
Diabetes. 1998 Sep;47(9):1464-71. doi: 10.2337/diabetes.47.9.1464.

引用本文的文献

1
Mechanisms of nebivolol-mediated effects on bFGF-induced vascular smooth muscle cell proliferation and migration.奈必洛尔介导的对碱性成纤维细胞生长因子诱导的血管平滑肌细胞增殖和迁移的影响机制。
Curr Res Pharmacol Drug Discov. 2025 Feb 20;8:100214. doi: 10.1016/j.crphar.2025.100214. eCollection 2025.
2
Physiological and metabolic functions of the β-adrenergic receptor and an approach to therapeutic achievements.β-肾上腺素能受体的生理和代谢功能及治疗成果的实现途径。
J Physiol Biochem. 2024 Nov;80(4):757-774. doi: 10.1007/s13105-024-01040-z. Epub 2024 Aug 15.
3
Agonist-induced desensitisation of β -adrenoceptors: Where, when, and how?
激动剂诱导的β-肾上腺素受体脱敏:在何处、何时以及如何发生?
Br J Pharmacol. 2019 Jul;176(14):2539-2558. doi: 10.1111/bph.14633. Epub 2019 Apr 7.
4
Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity.释放脂肪组织的产热潜能:药物调节及其对糖尿病和肥胖症治疗的意义。
Front Endocrinol (Lausanne). 2015 Nov 19;6:174. doi: 10.3389/fendo.2015.00174. eCollection 2015.
5
β(3) Receptors: Role in Cardiometabolic Disorders.β(3) 受体:在心脏代谢紊乱中的作用。
Ther Adv Endocrinol Metab. 2011 Apr;2(2):65-79. doi: 10.1177/2042018810390259.
6
Insights into the binding modes of human β₃-adrenergic receptor agonists with ligand-based and receptor-based methods.基于配体和受体方法的人β₃-肾上腺素能受体激动剂结合模式的研究。
Mol Divers. 2011 Nov;15(4):817-31. doi: 10.1007/s11030-011-9311-8. Epub 2011 Mar 20.
7
Tools to study beta3-adrenoceptors.研究β3肾上腺素能受体的工具。
Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb;374(5-6):385-98. doi: 10.1007/s00210-006-0127-5. Epub 2007 Jan 9.
8
Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer.β2-和β3-肾上腺素能受体基因多态性与乳腺癌易感性之间可能存在的关联。
Breast Cancer Res. 2001;3(4):264-9. doi: 10.1186/bcr304. Epub 2001 Apr 26.
9
The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts.在魁北克家族研究和瑞典肥胖受试者队列中,β3肾上腺素能受体基因的色氨酸64精氨酸突变对肥胖表型没有影响。
J Clin Invest. 1996 Nov 1;98(9):2086-93. doi: 10.1172/JCI119014.
10
Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.通过首个β3选择性拮抗剂芳氧基丙醇胺四氢萘对大鼠非典型β肾上腺素能受体进行功能鉴定。
Br J Pharmacol. 1996 Feb;117(3):435-442. doi: 10.1111/j.1476-5381.1996.tb15209.x.